These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12465139)

  • 1. Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.
    Seidman EG; Furst DE
    J Rheumatol; 2002 Dec; 29(12):2484-7. PubMed ID: 12465139
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.
    Marra CA; Esdaile JM; Anis AH
    J Rheumatol; 2002 Dec; 29(12):2507-12. PubMed ID: 12465143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPMT testing in rheumatology: any better than routine monitoring?
    Payne K; Newman W; Fargher E; Tricker K; Bruce IN; Ollier WE
    Rheumatology (Oxford); 2007 May; 46(5):727-9. PubMed ID: 17255139
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetics and rheumatology: Molecular mechanisms contributing to variability in drug response.
    Asanuma Y; Xie HG; Stein CM
    Arthritis Rheum; 2005 May; 52(5):1349-59. PubMed ID: 15880820
    [No Abstract]   [Full Text] [Related]  

  • 5. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
    Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in the rheumatic diseases.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics in pediatric rheumatology.
    Becker ML
    Curr Opin Rheumatol; 2012 Sep; 24(5):541-7. PubMed ID: 22732686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible clinical application of pharmacogenetics in rheumatology.
    Ferraccioli G
    J Rheumatol; 2003 Dec; 30(12):2517-20. PubMed ID: 14719186
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture.
    Cronstein BN
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):2-3. PubMed ID: 16932642
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetics and the impact on treatment protocols in patients with rheumatoid arthritis.
    Ibrahim I; Owen SA; Barton A
    Expert Rev Clin Immunol; 2012 Aug; 8(6):509-11. PubMed ID: 22992143
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus.
    Askanase AD; Wallace DJ; Weisman MH; Tseng CE; Bernstein L; Belmont HM; Seidman E; Ishimori M; Izmirly PM; Buyon JP
    J Rheumatol; 2009 Jan; 36(1):89-95. PubMed ID: 19040311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseases.
    Pickenpack A; Straub RH; Distler O; Hammond A; Oellerich M; Schölmerich J; Lang B; Schütz E
    Rheumatology (Oxford); 2000 Dec; 39(12):1435-6. PubMed ID: 11136898
    [No Abstract]   [Full Text] [Related]  

  • 13. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.
    Clunie GP; Lennard L
    Rheumatology (Oxford); 2004 Jan; 43(1):13-8. PubMed ID: 14566029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics in the rheumatic diseases.
    Cronstein BN
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii25-ii27. PubMed ID: 15479867
    [No Abstract]   [Full Text] [Related]  

  • 15. Azathioprine treatment and thiopurine metabolism in rheumatic diseases. Introduction and first results of investigation.
    Stolk JN; Boerbooms AM; De Abreu RA; van de Putte LB
    Adv Exp Med Biol; 1998; 431():487-93. PubMed ID: 9598116
    [No Abstract]   [Full Text] [Related]  

  • 16. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
    Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
    J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.
    Ferraccioli G; De Santis M; Tolusso B
    Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
    Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics: implications for therapy in rheumatic diseases.
    Davila L; Ranganathan P
    Nat Rev Rheumatol; 2011 Aug; 7(9):537-50. PubMed ID: 21826093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.
    Polk BI; Becker ML
    Discov Med; 2013 Dec; 16(90):267-75. PubMed ID: 24333406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.